SCS
KRYS icon

Sound Capital Solutions’s Krystal Biotech KRYS Stock Holding History

Sound Capital Solutions’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
+1,705
New +$509K 0.15% 98

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Sound Capital Solutions's KRYS Position: Q2 2026 in Review

Sound Capital Solutions opened a new position in Krystal Biotech (KRYS) in Q2 2026: 1,705 shares worth $634K. The stake represents 0.15% of the portfolio and ranks #98 among its holdings.

398 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Sound Capital Solutions held 1,705 shares of Krystal Biotech worth $634K as of Q2 2026.
  • Krystal Biotech was a new Sound Capital Solutions position in Q2 2026.
  • Krystal Biotech made up 0.15% of Sound Capital Solutions's portfolio in Q2 2026, its #98 holding.
  • 398 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Sound Capital Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.